RESPONDR Trademark

Trademark Overview

On Wednesday, June 30, 2021, a trademark application was filed for RESPONDR with the United States Patent and Trademark Office. The USPTO has given the RESPONDR trademark a serial number of 90804108. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Tuesday, May 28, 2024. This trademark is owned by Prometheus Laboratories Inc.. The RESPONDR trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical testing services assessing the likelihood of a medical patient achieving a set therapeutic target with a specific pharmaceutical in the field of autoimmune diseases
respondr

General Information

Serial Number90804108
Word MarkRESPONDR
Filing DateWednesday, June 30, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateTuesday, May 28, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 26, 2022

Trademark Statements

Pseudo MarkRESPONDER
Goods and ServicesMedical testing services assessing the likelihood of a medical patient achieving a set therapeutic target with a specific pharmaceutical in the field of autoimmune diseases

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, September 12, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePrometheus Laboratories Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NamePrometheus Laboratories Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Saturday, July 3, 2021NEW APPLICATION ENTERED
Sunday, September 12, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 21, 2022ASSIGNED TO EXAMINER
Wednesday, March 23, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 6, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 26, 2022PUBLISHED FOR OPPOSITION
Tuesday, April 26, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 21, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 29, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 29, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 29, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, November 29, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 30, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, November 30, 2022SOU EXTENSION 1 FILED
Wednesday, November 30, 2022SOU EXTENSION 1 GRANTED
Friday, December 2, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 26, 2023SOU TEAS EXTENSION RECEIVED
Friday, May 26, 2023SOU EXTENSION 2 FILED
Friday, May 26, 2023SOU EXTENSION 2 GRANTED
Tuesday, May 30, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 29, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 29, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 29, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 5, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, December 5, 2023SOU EXTENSION 3 FILED
Tuesday, December 5, 2023SOU EXTENSION 3 GRANTED
Thursday, December 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 28, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, May 28, 2024SOU EXTENSION 4 GRANTED
Tuesday, May 28, 2024SOU EXTENSION 4 FILED
Wednesday, May 29, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

respondr medical specific pharmaceutical field diseases autoimmune target achieving services testing